Patent ID: 8293223

Claim:
A method of treating an individual who has an injury to skin, comprising administering to the individual therapeutically effective amount of isolated human placental stem cells, wherein said placental stem cells are: OCT-4 + , CD34 − , CD10 + , CD29 + , CD44 + , CD45 − , CD54 + , CD90 + , SH3 + , SH4 + , SSEA3 − , and SSEA4 − , wherein OCT-4 is octamer binding protein 4; OCT-4 + , CD34 − , SSEA3 − and SSEA4 − ; OCT-4 + and CD34 − , and additionally SH3 + or SH4 + ; or CD34 − and one or more of CD29 + , CD45 − , CD90 + , SH2 + , SH3 + , SH4 + , or MHC Class II − .